Therapy Areas: Inflammatory Diseases
14 June 2019 - - US-based biopharmaceutical company Prelude Therapeutics has secured USD 60m in series B financing; taking its total investments to date to USD 95m, the company said.
The financi...
14 June 2019 - - US-based biopharmaceutical company Pfizer Inc. (NYSE: PFE) has received positive results from ORAL Shift, a Phase 3b/4 study in adult patients with moderately to severely active rheum...
14 June 2019 - - The US Food and Drug Administration has accepted US-based Genentech's supplemental Biologics License Application and granted Priority Review for the use of Rituxan (rituxima...
14 June 2019 - Biopharmaceutical company Navidea Biopharmaceuticals Inc (NYSE American:NAVB) said on Thursday that it has priced its underwritten public offering of 8,000,000 shares of common stock at...
13 June 2019 - Switzerland-based Novartis' Cosentyx (secukinumab) has achieved its primary and key secondary endpoint in the Maximise study of psoriatic arthritis, it was reported yesterday.The p...
12 June 2019 - - US-based biotechnology company Genentech has received positive topline results for NOBILITY, a Phase II clinical trial investigating the safety and efficacy of Gazyva (obinutuzum...
Related Headlines